RaySearch Laboratories AB (STU:27R) Forward Dividend Yield %: 1.79% (As of Jul. 03, 2026)


STU:27R RaySearch Laboratories AB STU:27R
86 GF Score
Price €21.02
GF Value €17.21
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Forward Dividend Yield %?

RaySearch Laboratories AB STU:27R +3.44% 86 Forward Dividend Yield % is 1.79% as of Jul. 03, 2026. GuruFocus rates STU:27R with a GF Score™ of 86/100 and a GF Value™ of €17.21. The stock has 2 warning signs investors should review. Among 275 Healthcare Providers & Services companies, RaySearch Laboratories AB ranks worse than 64.73% on this metric.

As of today (2026-07-03), the Forward Annual Dividend Yield of RaySearch Laboratories AB is 1.79%.

As of today (2026-07-03), the Trailing Annual Dividend Yield of RaySearch Laboratories AB is 1.79%.

STU:27R's Forward Dividend Yield % is ranked worse than
64.73% of 275 companies
in the Healthcare Providers & Services industry
Industry Median: 2.53 vs STU:27R: 1.79

RaySearch Laboratories AB's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

During the past 12 months, RaySearch Laboratories AB's average Dividends Per Share Growth Rate was 328.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of RaySearch Laboratories AB was 44.10% per year. The lowest was 44.10% per year. And the median was 44.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


RaySearch Laboratories AB  (STU:27R) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


RaySearch Laboratories AB Forward Dividend Yield % Related Terms


STU:27R vs VEEV, BTSG, TEM: Forward Dividend Yield % Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB Forward Dividend Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Forward Dividend Yield % falls into.


STU:27R
86GF Score
RaySearch Laboratories AB STU:27R
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

RaySearch Laboratories AB Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
SEK 4.0000002026-05-082026-05-112026-05-15Cash DividendannuallySEK:EUR 0.092436

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

RaySearch Laboratories AB's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.369744/21.02
=1.76 %

Current Share Price is €21.02.
RaySearch Laboratories AB's Dividends per Share for the forward twelve months is calculated as €0.369744 * 1 = €0.369744.

RaySearch Laboratories AB's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.369744/21.02
=1.76 %

Current Share Price is €21.02.
RaySearch Laboratories AB's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.369744.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 1.79% mean?
RaySearch Laboratories AB (STU:27R) has a Forward Dividend Yield % of 1.79% as of Jul. 03, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on RaySearch Laboratories AB and its competitors. According to the industry distribution chart, RaySearch Laboratories AB ranks #178 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 64.7%.
Is RaySearch Laboratories AB's Forward Dividend Yield % too high?
RaySearch Laboratories AB's current Forward Dividend Yield % is 1.79%. The Healthcare Providers & Services industry median Forward Dividend Yield % is 2.53. RaySearch Laboratories AB's value of 1.79% is 29.2% below this industry median. Based on the distribution chart, RaySearch Laboratories AB ranks #178 out of 275 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, RaySearch Laboratories AB has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Forward Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #178 out of 275 companies for Forward Dividend Yield %. This places RaySearch Laboratories AB in the lower half of its industry. The industry median Forward Dividend Yield % is 2.53. RaySearch Laboratories AB's value of 1.79% is 29.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.53, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RaySearch Laboratories AB's current Forward Dividend Yield % of 1.79% is 29.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on RaySearch Laboratories AB and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RaySearch Laboratories AB's current Forward Dividend Yield % is 1.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
RaySearch Laboratories AB (STU:27R) has a current Forward Dividend Yield % of 1.79%. The stock's GF Value™ is €17.21, compared to a current price of €21.02 — trading 22.1% above its estimated fair value. The current Forward Dividend Yield % is 1.79% and 29.2% below the Healthcare Providers & Services industry median of 2.53. RaySearch Laboratories AB's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For RaySearch Laboratories AB (STU:27R), the current Forward Dividend Yield % is 1.79% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (STU:27R) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of €21.02 is trading 22.1% above its estimated GF Value™ of €17.21.

Key valuation signals for STU:27R:

  • Forward Dividend Yield %: 1.79%
  • GF Value™: €17.21 vs. price of €21.02 (22.1% above fair value)
  • GF Score™: 86/100 with 2 warning signs
  • Industry Position: 29.2% below the Healthcare Providers & Services median (#178 of 275)

No single metric tells the full story. See the STU:27R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
86GF Score

Get the complete analysis for STU:27R

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.02
Price
€17.21
GF Value